LYEL – lyell immunopharma, inc. (US:NASDAQ)
Stock Stats
News
Lyell Immunopharma (NASDAQ:LYEL) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Lyell Immunopharma reports Q3 results [Seeking Alpha]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025 [Yahoo! Finance]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025 
Lyell acquires worldwide rights from ICT to CAR T-cell therapy [Yahoo! Finance]
Form S-3 Lyell Immunopharma, Inc.
Form 8-K Lyell Immunopharma, Inc. For: Dec 03
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: ARCH Venture Fund IX, L.P.
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: Foresite Capital Fund IV, L.P.
Form 4 Lyell Immunopharma, Inc. For: Nov 10 Filed by: Seely Lynn
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.